(Q40218154)

18 September 2017

Cytotoxic activity of gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukemia correlates with the expression of protein kinase Syk. (English)

1 reference

18 September 2017

1 reference

acute myeloid leukemia

1 reference

L Balaian

1

1 reference

18 September 2017

E D Ball

series ordinal

2

1 reference

18 September 2017

19 October 2006

1 reference

18 September 2017

1 reference

18 September 2017

20

1 reference

18 September 2017

12

1 reference

18 September 2017

2093-2101

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404437

18 September 2017

0 references

cites work

The sialoadhesin CD33 is a myeloid-specific inhibitory receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: engagement of CD33 induces apoptosis of leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

p75/AIRM1 and CD33, two sialoadhesin receptors that regulate the proliferation or the survival of normal and leukemic myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

Heteroclitic CD33 peptide with enhanced anti-acute myeloid leukemic immunogenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

Targeted therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

Interleukin-3 activates Syk in a human myeloblastic leukemia cell line, AML193.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

Signal transduction involved in MCP-1-mediated monocytic transendothelial migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

A novel Syk kinase-selective inhibitor blocks antigen presentation of immune complexes in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

The ins and outs of getting in: structures and signals that enhance BCR or Fc receptor-mediated antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

Unexpected functions of FcepsilonRI on antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

Visualization of Syk-antigen receptor interactions using green fluorescent protein: differential roles for Syk and Lyn in the regulation of receptor capping and internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

Involvement of p72syk kinase, p53/56lyn kinase and phosphatidyl inositol-3 kinase in signal transduction via the human B lymphocyte antigen CD22

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

Analysis of tyrosine phosphorylation-dependent interactions between stimulatory effector proteins and the B cell co-receptor CD22

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

CD22 regulates B cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

Direct effect of bispecific anti-CD33 x anti-CD64 antibody on proliferation and signaling in myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

The inhibitory effect of anti-CD33 monoclonal antibodies on AML cell growth correlates with Syk and/or ZAP-70 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

Hypermethylation of the spleen tyrosine kinase promoter in T-lineage acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

The Syk tyrosine kinase: a new negative regulator in tumor growth and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

Syk: a new player in the field of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

Inhibitors of DNA methylation: beyond myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

Epigenetic treatment of hematopoietic malignancies: in vivo targets of demethylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

DNA methylation and cancer therapy: new developments and expectations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

7 January 2021

Up-regulation of Syk activity during HL60 cell differentiation into granulocyte but not into monocyte/macrophage-lineage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

7 January 2021

Fc epsilon RI aggregation induces tyrosine phosphorylation of a novel 72 kDa protein downstream of Syk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

7 January 2021

Signal transduction via both human low-affinity IgG Fc receptors, Fc gamma RIIa and Fc gamma RIIIb, depends on the activity of different families of intracellular kinases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404437

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404437

1 reference

Dimensions Publication ID

18 September 2017

1027414498

0 references

Fatcat ID

release_l7f4sz276renjay3futf55fpti

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/l7f4sz276renjay3futf55fpti

24 November 2022

mapped directly with Wikidata item

1 reference